1
|
Marino-Martínez IA, Martínez-Castro AG, Peña-Martínez VM, Acosta-Olivo CA, Vílchez-Cavazos F, Guzmán-López A, Pérez Rodríguez E, Romero-Díaz VJ, Ortega-Blanco JA, Lara-Arias J. Human amniotic membrane intra-articular injection prevents cartilage damage in an osteoarthritis model. Exp Ther Med 2018; 17:11-16. [PMID: 30651759 PMCID: PMC6307525 DOI: 10.3892/etm.2018.6924] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2017] [Accepted: 08/09/2018] [Indexed: 12/17/2022] Open
Abstract
Osteoarthritis (OA) is a degenerative joint disease that affects the soft tissues and bones of involved articulations as a result of deregulation between synthesis and extracellular matrix degradation in articular cartilage. The present study evaluated the effect of intra-articular injection of human amniotic membrane (AM) as a treatment in an OA animal model in the knee. Chemical OA was developed in the knees of New Zealand rabbits. Once OA was established, the right knees only were treated with an intra-articular injection of human AM, with the left knees considered as a negative control group. The evaluation was performed at 3 and 6 weeks post-treatment. At 3 weeks post-injection, the cartilage exhibited fibrillation, erosion, cracks and cell clusters in the negative control group, but not in the treated group (P=0.028). At 6 weeks post-injection, the left knees exhibited hypertrophy, cracks, cell clusters, decreased matrix staining and structure loss. However, the right knees exhibited cell clusters without evidence of disruption in cartilage integrity (P=0.015). These results suggested that the intra-articular injection of human AM delays histological changes of cartilage in OA.
Collapse
Affiliation(s)
- I A Marino-Martínez
- Pathology Service, Hospital Universitario 'Dr. José E. González', Monterrey, NL 64460, Mexico
| | - A G Martínez-Castro
- Orthopedics and Traumatology Service, Hospital Universitario 'Dr. José E. González', Monterrey, NL 64460, Mexico
| | - V M Peña-Martínez
- Orthopedics and Traumatology Service, Hospital Universitario 'Dr. José E. González', Monterrey, NL 64460, Mexico
| | - C A Acosta-Olivo
- Orthopedics and Traumatology Service, Hospital Universitario 'Dr. José E. González', Monterrey, NL 64460, Mexico
| | - F Vílchez-Cavazos
- Orthopedics and Traumatology Service, Hospital Universitario 'Dr. José E. González', Monterrey, NL 64460, Mexico
| | - A Guzmán-López
- Obstetrics and Gynecology Service, Hospital Universitario 'Dr. José E. González', Monterrey, NL 64460, Mexico
| | | | - V J Romero-Díaz
- Department of Histology, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, NL 64460, Mexico
| | | | - J Lara-Arias
- Orthopedics and Traumatology Service, Hospital Universitario 'Dr. José E. González', Monterrey, NL 64460, Mexico
| |
Collapse
|
2
|
Simental-Mendía M, Lara-Arias J, Álvarez-Lozano E, Said-Fernández S, Soto-Domínguez A, Padilla-Rivas GR, Martínez-Rodríguez HG. Cotransfected human chondrocytes: over-expression of IGF-I and SOX9 enhances the synthesis of cartilage matrix components collagen-II and glycosaminoglycans. ACTA ACUST UNITED AC 2015; 48:1063-70. [PMID: 26445237 PMCID: PMC4661021 DOI: 10.1590/1414-431x20154732] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2015] [Accepted: 07/08/2015] [Indexed: 01/19/2023]
Abstract
Damage to cartilage causes a loss of type II collagen (Col-II) and glycosaminoglycans
(GAG). To restore the original cartilage architecture, cell factors that stimulate
Col-II and GAG production are needed. Insulin-like growth factor I
(IGF-I) and transcription factor SOX9are
essential for the synthesis of cartilage matrix, chondrocyte proliferation, and
phenotype maintenance. We evaluated the combined effect of IGF-I and
SOX9 transgene expression on Col-II and GAG production by
cultured human articular chondrocytes. Transient transfection and cotransfection were
performed using two mammalian expression plasmids (pCMV-SPORT6), one for each
transgene. At day 9 post-transfection, the chondrocytes that were over-expressing
IGF-I/SOX9 showed 2-fold increased mRNA
expression of the Col-II gene, as well as a 57% increase in Col-II
protein, whereas type I collagen expression (Col-I) was decreased by
59.3% compared with controls. The production of GAG by these cells increased
significantly compared with the controls at day 9 (3.3- vs
1.8-times, an increase of almost 83%). Thus,
IGF-I/SOX9 cotransfected chondrocytes may be
useful for cell-based articular cartilage therapies.
Collapse
Affiliation(s)
- M Simental-Mendía
- Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, NL, Mexico
| | - J Lara-Arias
- Autonomous University of Nuevo León, Laboratory of Tissue Engineering, Bone and Tissue Bank, Universitary Hospital, Monterrey, NL, Mexico
| | - E Álvarez-Lozano
- Autonomous University of Nuevo León, Laboratory of Tissue Engineering, Bone and Tissue Bank, Universitary Hospital, Monterrey, NL, Mexico
| | - S Said-Fernández
- Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, NL, Mexico
| | - A Soto-Domínguez
- Department of Histology, Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, NL, Mexico
| | - G R Padilla-Rivas
- Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, NL, Mexico
| | - H G Martínez-Rodríguez
- Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, NL, Mexico
| |
Collapse
|